Arrowstreet Capital, Limited Partnership Axogen, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $108 Billion
- Q1 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Axogen, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 17,522 shares of AXGN stock, worth $126,859. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,522
Previous 53,093
67.0%
Holding current value
$126,859
Previous $363,000
61.16%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AXGN
# of Institutions
125Shares Held
34.1MCall Options Held
80.7KPut Options Held
3.3K-
Arrow Mark Colorado Holdings LLC Denver, CO4.73MShares$34.2 Million0.47% of portfolio
-
Black Rock Inc. New York, NY3.23MShares$23.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.18MShares$23 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT3.11MShares$22.5 Million2.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.41MShares$17.5 Million0.0% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $306M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...